Flu Vaccines Significantly Reduce Pediatric Hospitalization Risk

Seasonal influenza vaccinations significantly lower the risk of medical visits and hospitalizations for children, according to data from public health agencies and medical research. Evidence indicates that these vaccines are effective across multiple flu seasons and various age groups, providing a critical layer of protection against severe illness and life-threatening complications.

During the 2023–2024 flu season, interim estimates from the Centers for Disease Control and Prevention (CDC) published on February 29, 2024, showed that flu vaccines substantially reduced the risk of flu-related medical visits and hospitalizations across all age groups. For vaccinated children, the risk of flu medical visits was reduced by approximately two-thirds, while flu-related hospitalizations were reduced by about half.

The 2023–2024 data indicated that the vaccines were effective against both influenza A and B viruses. The CDC noted that some effectiveness estimates for this period were higher than those previously observed, even during seasons where the vaccine was well-matched to the circulating strains.

Comparison of Pediatric and Adult Effectiveness

The protective impact of the flu vaccine varies by age. In the 2023–2024 season, vaccinated adults experienced a 50 percent reduction in flu medical visits and a reduction in hospitalizations of approximately 40 percent.

Broadly, the CDC reported on August 14, 2024, that flu vaccination generally provides a level of protection against illness in children similar to that seen in adults aged 18 to 64. However, for adults aged 65 and older, higher dose or adjuvanted vaccines are recommended due to their increased effectiveness for that specific demographic.

Reduction in Severe Outcomes and Mortality

Beyond preventing general illness, vaccination is linked to a decrease in the most severe outcomes. A study from 2022 highlighted that flu vaccination reduced the risk of severe, life-threatening influenza in children by 75 percent.

Research published in the journal Pediatrics in 2017 provided evidence regarding the vaccine’s impact on mortality. The study, which analyzed data from four flu seasons between 2010 and 2014, found that flu vaccination reduced the risk of flu-associated death by 65 percent among healthy children.

For children with underlying, higher-risk medical conditions, the same 2017 study found that vaccination reduced the risk of flu-associated death by 51 percent.

Further historical data from a 2020 study focused on the 2018-2019 flu season found that vaccination reduced flu-related hospitalizations by 41 percent and cut flu-related emergency department visits in half for children between 6 months and 17 years old.

Vaccination Strategies and Global Trends

The effectiveness of the vaccine can be influenced by the dosing schedule. The CDC has noted that in several studies, vaccine effectiveness was higher among children who received two doses of the flu vaccine during their first season of vaccination, as recommended, compared to children who received only a single dose.

On a global scale, reporting indicates that flu vaccines provide strong protection for children across Europe. However, some strains remain more challenging to combat; specifically, the H3N2 virus has proven harder to stop than other strains.

The American Academy of Pediatrics (AAP) emphasized on January 22, 2026, that decades of real-world evidence confirm that seasonal flu vaccines decrease the risk of illness, hospitalization, and death in children. A subsequent report in Pediatrics indicated that increasing the uptake of pediatric influenza vaccinations would prevent additional outpatient visits and hospitalizations.

Public health guidance continues to recommend yearly flu vaccinations for children and adults as long as influenza viruses are spreading within the community.